title: Pharmacokinetic monitoring is still required for intravenous busulfan in SCT for small children.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Nagasawa
authors.forename: Noriko
authors.initials: N
authors.lastname: Mitsuiki
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Ono
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Takagi
authors.forename: Hiromi
authors.initials: H
authors.lastname: Oda
authors.forename: Masato
authors.initials: M
authors.lastname: Yasuhara
authors.forename: Shuki
authors.initials: S
authors.lastname: Mizutani
mesh_terms: D002066:Busulfan / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002648:Child; D016903:Drug Monitoring; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D019653:Myeloablative Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019172:Transplantation Conditioning / Q000379:methods*; D055815:Young Adult
chemical_list: D019653:Myeloablative Agonists; D002066:Busulfan